Marechale Capital Plc - Final Results
PR Newswire
LONDON, United Kingdom, August 22
22 August 2025
Marechale Capital plc
("Marechale" or the "Company")
Financial Statements for the Year Ended 30 April 2025
Marechale Capital Plc (AIM: MAC), an established City of London based corporate finance house with a long-term track record and a strong reputation for advising and financing high growth consumer brands, leisure, clean energy, mineral extraction and technology companies, is pleased to announce its audited final results for the year ended 30 April 2025 (the "Period").
Chairman's Statement
As reported in the interim results statement in December 2024, it has been a challenging year generally and in the hospitality sector in particular, as a number of businesses negotiated a continuing period of market uncertainty, with increased inflation driven overheads, compounded by a squeeze in discretionary spending. However, against this challenging backdrop, there are significant market opportunities for Marechale's clients.
The Company entered the Period with good levels of business activity and funded clients in both the hospitality sector, as well as clients in other high growth sectors. Completed fund raising projects include further equity funding for the Chestnut Group, the leading East Anglian Inn Group, loan refinancing and growth equity funding for Brewhouse & Kitchen, the UK's largest brew pub chain, and equity funding was raised for Stubben Edge Capital Ltd, the Insurance industry platform. Also, additional funding has been raised for Weardale Lithium at a premium valuation.
Marechale continues to generate professional services income by providing advice to its clients. In the last year this included strategic and funding advice for the Chestnut Group and Brewhouse & Kitchen. In addition, as announced to the market in March Marechale acted as exclusive adviser on the sale of Randalls, Guernsey's largest hospitality businesses as well as providing advice to the shareholder in the UK's leading resort business and the owner of Rileys, the national snooker business.
Significant progress continues to be made with the lithium extraction business, Weardale Lithium Ltd, and our pipeline of new and increasingly diversified projects remains robust.
Weardale Lithium Ltd is Marechale's largest investment, comprising 467,000 founder shares and 20,800 options with a combined value of £2.85 million which has been recorded in the Balance Sheet. Weardale has proved lithium reserves in its secured mineral rights in Co. Durham and as announced to the Market in February became the UK's first 100% direct lithium extraction plant to receive planning permission to build a pilot plant to use its existing boreholes. Marechale remains optimistic for a positive future outcome on this investment.
The total value of the Company's net assets has reduced to £3,037,000 in 2025 (2024: £3,346,000) equivalent to 2.9p/share (2024: 3.1p/share), due to a combination of Operating Losses and Investment Losses, the latter by taking advantage of an opportunity to sell some Weardale shares for cash, acquired as founder shares, albeit at a discount to their current value. This is in line with Marechale's stated strategy of using its balance sheet to co-invest in its client companies. Cash at bank at 30th April was £212,150.
Please note that, within the rules of the Accounting Standards, the Board took the decision in 2024 to declare separately as 'Exceptional Costs' various impairment provisions for bad debts and loan notes owed by two Investee Companies. Please be advised that at the time of writing, one of these companies remains trading but is under severe financial distress; the other is now in Administration: however, we managed to recover £10,300 from the latter which has been credited back to this year's P&L.
It is also worth noting that the Company has £770,000 of unused capital tax losses to offset against any possible future tax liability on realisation of gains.
Marechale's revenue for the year saw a substantial reduction to £409,500 compared to £668,800, in the previous financial year. In spite of this, gross profit increased to £274,000 compared to £197,000 in 2024 mainly due to lower commissions paid to 3rd parties on fundraising income.
Whilst we continue to navigate through various market challenges, I am pleased to report a significant reduction in Marechale's operating loss for the year, from £296,000 in 2024 to £226,000 this year, mainly due to an improved gross margin of £275,000 (67%) compared to £197,000 (29%) in 2024. Marechale's net loss before tax for the year stands at £337,000, a notable deterioration from the net loss of £183,000 reported in 2024. The major year-on-year swing was caused by a significant uplift on the value of investments in 2024 - principally Weardale - offset by Exceptional Costs, versus in 2025, the sale of investments at a discount - to raise cash as mentioned above. It is worth noting that we expect to record an uplift in the value of investments based on an equity fundraising already in progress but not yet closed. Administrative expenses remained steady at £500,000 (2024: £494,000).
The Company's focus is to use its reputation and deal flow as a corporate finance adviser to build shareholder value in Marechale's balance sheet. This has been achieved by negotiating equity and warrant positions, and joint venture arrangements as part of its terms of engagement with growth company clients. Marechale's historical investment performance has been excellent in this regard, having achieved double digit internal rates of return across the total of all the companies that it has funded since 2010. The Board is confident that the investment in Weardale Lithium will deliver an uplift in value in due course.
Since Chris Kenning acquired his shareholding in Marechale and joined the Board, we have been working together on a number of corporate finance transactions with him and his business Stubben Edge Capital Ltd. We are pleased to report that the first transaction has been achieved, earning commission fees and warrants for Marechale. And we continue to explore how we can digitize our transaction processes for our early-stage corporate finance projects.
Whilst the current economic climate remains challenging, the Board remains positive about the investments that it holds in its client companies, and optimistic that the Company, with its sufficient cash reserves, will continue to generate further uplifts on its current and future equity and warrant investments, both in the short and longer term. The Company continues to develop further its proven track record as a corporate finance adviser by seeking further deal flow in the high growth £10-100 million Enterprise Value PE sector.
Hopefully there is now the beginning of a shift in sentiment towards investing in the SME space, driven by the Government's drive for growth, and we hope to see support and incentives towards realising this and encouraging investment in businesses that Marechale works with.
The Board is working on a number of initiatives to create further value for shareholders, and the plan is to continue to develop Marechale's strategic funding partnerships with the objective of enhancing shareholder value.
The Board believes, having had a number of approaches over the last few months, that the current disruption in the SME Advisory and Broking market presents an excellent opportunity to attract good quality people into Marechale's cost effective business structure that allows them to make good earnings and have a shared interest as shareholders in Marechale's balance sheet.
As we look to the future, the Board remains committed to building on positive momentum. The Company will continue to focus on enhancing revenue streams and delivering value to shareholders.
In closing, I would like to extend my heartfelt thanks to shareholders, employees, and clients for their continued support and confidence in the Company. The Board looks forward to another year of progress and achievement.
Mark Warde-Norbury
Chairman
21 August 2025
This announcement contains inside information for the purposes of the UK Market Abuse Regulation.
For further information please contact:
Marechale Capital plc Mark Warde-Norbury / Patrick Booth-Clibborn | Tel: +44 (0)20 7628 5582 |
Cairn Financial Advisers LLP (Nomad and Broker) Jo Turner / Sandy Jamieson | Tel: +44 (0)20 7213 0880 |
Statement of Comprehensive Income
For year ended 30 April 2025
Year ended | Year ended | |||||
30-Apr | 30-Apr | |||||
Notes | 2025 | 2024 | ||||
(£) | (£) | |||||
Revenue | 4 | 409,413 | 668,816 | |||
Cost of sales | (134,731) | (471,433) | ||||
Gross profit | 274,682 | 197,384 | ||||
Administrative expenses | (500,477) | (493,643) | ||||
Operating loss | 5 | (225,795) | (296,260) | |||
Net interest received/(paid) | 975 | (428) | ||||
Other gains/(losses) | 6 | (122,822) | 223,004 | |||
Exceptional items | 7 | 10,316 | (109,303) | |||
Loss before tax | (337,325) | (182,987) | ||||
Taxation | 8 | - | - | |||
Loss for the year | (337,325) | (182,987) | ||||
Earnings per share | (Pence) | (Pence) | ||||
Continuing operations | - Basic | 10 | (0.32) | (0.18) | ||
- Diluted | 10 | (0.32) | (0.18) | |||
Loss for the year | (337,325) | (182,987) | ||||
Total recognised comprehensive profit | ||||||
(all attributable to owners of the company) | (337,325) | (182,987) |
The notes form an integral part of the financial statements.
Statement of Financial Position
As at 30 April 2025
Year ended | Year ended | |||||
30-Apr | 30-Apr | |||||
2025 | 2024 | |||||
Notes | (£) | (£) | ||||
Current assets | ||||||
Investment in subsidiary | 11 | 2 | 2 | |||
Equity investments at fair value through profit and loss | 12 | 2,807,827 | 3,039,659 | |||
Warrants at fair value through profit and loss | 13 | 58,800 | 108,482 | |||
Trade and other receivables | 14 | 104,426 | 34,590 | |||
Cash and cash equivalents | 15 | 212,150 | 248,196 | |||
Total current assets | 3,183,205 | 3,430,929 | ||||
Total assets | 3,183,205 | 3,430,929 | ||||
Current liabilities | ||||||
Trade and other payables | 16 | (133,489) | (62,035) | |||
Borrowings | 17 | (10,000) | (10,000) | |||
Total current liabilities | (143,489) | (72,035) | ||||
Net current assets | 3,039,716 | 3,358,895 | ||||
Long-term liabilities | ||||||
Borrowings | 17 | (2,500) | (12,500) | |||
Net assets | 3,037,216 | 3,346,395 | ||||
Equity | ||||||
Capital and reserves attributable to equity shareholders | ||||||
Share capital | 18 | 847,530 | 847,530 | |||
Share premium | 18 | 481,290 | 481,290 | |||
Reserve for own shares | (50,254) | (50,254) | ||||
Reserve for share based payments | 178,315 | 150,168 | ||||
Retained earnings | 1,580,336 | 1,917,661 | ||||
3,037,216 | 3,346,395 | |||||
The financial statements were approved by the Board of Directors and authorised for issue on 21 August 2025. | ||||||
They were signed on its behalf by: | ||||||
Mark Warde-Norbury | ||||||
Director | ||||||
Company No: | 03515836 |
The notes form an integral part of the financial statements.
Statement of Changes in Equity
For year ended 30 April 2025
Share capital | Share premium | Reserve for own shares | Reserve for share based payments | Retained earnings | Total | |
Balance at 30 April 2023 | 763,690 | 329,330 | (50,254) | 83,988 | 2,100,648 | 3,227,401 |
Loss for the financial year | - | - | - | - | (182,987) | (182,987) |
Share based payments in the year | - | - | - | 66,180 | - | 66,180 |
Issued in year | 83,840 | 151,960 | - | - | - | 235,800 |
Total movement in shareholders funds | 83,840 | 151,960 | - | 66,180 | (182,987) | 118,993 |
Balance at 30 April 2024 | 847,530 | 481,290 | (50,254) | 150,168 | 1,917,661 | 3,346,394 |
Loss for the financial year | - | - | - | - | (337,325) | (337,325) |
Share based payments in the year | - | - | - | 28,147 | - | 28,147 |
Issued in year | - | - | - | - | - | 0 |
Total movement in shareholders funds | - | - | - | 28,147 | (337,325) | (309,178) |
Balance at 30 April 2025 | 847,530 | 481,290 | (50,254) | 178,315 | 1,580,336 | 3,037,216 |
The notes form an integral part of the financial statements.
Statement of Changes of Cash Flows
For year ended 30 April 2025
Cash Flow Statement | Note | Year ended | Year ended | |
Year ended 30 April 2025 | 30-Apr | 30-Apr | ||
2025 | 2024 | |||
(£) | (£) | |||
Net cash from operating activities | ||||
Loss before tax | (337,325) | (182,987) | ||
Reverse provision for share based payments | 28,147 | 66,180 | ||
Reverse unrealised losses/ (gains) on fair value investment through profit and loss | 31,832 | (228,406) | ||
(Add back)/reverse provision for exceptional costs | (10,316) | 109,303 | ||
Reverse realised gains on warrants | (8,847) | - | ||
Reverse losses on disposal of equity investments | 99,837 | 5,402 | ||
Reverse net interest (income)/ expense | (975) | 428 | ||
Operating cash outflows before movements in working capital | (197,648) | (230,080) | ||
Movement in working capital | ||||
(Increase)/decrease in receivables | (59,520) | 3,539 | ||
Increase/(decrease) in payables | 71,455 | (29,523) | ||
Tax paid | - | - | ||
11,935 | (25,983) | |||
Cash outflow from operating activities | (185,713) | (256,063) | ||
Investment activities | ||||
Interest received | 1,390 | 272 | ||
Expenditure on equity investments | - | (6,572) | ||
Proceeds from sale of equity investments and warrants through profit and loss | 158,692 | 2,664 | ||
Cash inflow/(outflow) from investing activities | 160,082 | (3,636) | ||
Financing | ||||
Issue of ordinary share capital | - | 235,800 | ||
Repayment of borrowings | (10,000) | (10,000) | ||
Interest payable | (415) | (699) | ||
Cash (outflow)/inflow from financing activities | (10,415) | 225,101 | ||
Net decrease in cash and cash equivalents | (36,046) | (34,599) | ||
Cash and cash equivalents at start of the financial year | 248,196 | 282,795 | ||
Cash and cash equivalents at end of the financial year | 15 | 212,150 | 248,196 |
The notes form an integral part of the financial statements.
Notes to the Financial Statements
Year ended 30 April 2025
1. General information
Marechale Capital PLC is a company registered in England and Wales under the Companies Act 2006. The Company's principal activities are the provision of professional services advice and broking services to companies. The financial statements are presented in pounds sterling, the currency of the primary economic environment in which the Company operates.
The Company's registered office and principal place of business is 46 New Broad Street, London, EC2M 1JH.
The Company's registered number is 03515836.
2. Basis of preparation
a. Going concern
In establishing the applicability of the going concern basis, the Directors have made enquiries as to the financial resources of the Company. The Company has unpredictable revenue due to the nature of corporate finance advisory and the reliance upon deal-driven transactions, however as at the year end the company had £212k of cash reserves (2024: £248k) which as at that date equated to approximately 7 months of cash overheads. Whilst the company generated operating losses of £226k in the financial year (2024: £296k) the directors remain confident that the project pipeline will generate sufficient income on top of the cash reserves in order to meet the company's liabilities as they fall due over the next twelve months from the date of approving these financial statements. Furthermore, there is the ability to fund working capital by equity issues, sales of investments and/or warrants and deferral of directors' salaries.
b. Basis of accounting
These financial statements have been prepared in accordance with UK Adopted International Reporting Standards ('IFRS'). IFRS Interpretations Committee ('IFRS IC') interpretations and the Companies Act 2006 applicable to companies reporting under IFRS.
The financial statements have been prepared on the historical cost basis as modified by the valuation of certain financial instruments, as described below.
The Directors have chosen not to prepare consolidated accounts because the two subsidiaries, Marechale Limited and Marechale Capital Investments Limited, are both dormant, have never traded, and therefore highly immaterial to the financial statements.
Subsidiaries are entities over which the Group has control, being the power to govern the financial and operating policies of the acquired entity so as to obtain benefits from its activities.
3. Business and geographical segments
The directors consider that there is only one activity undertaken by the Company, that of corporate finance professional services advisory. All of this activity was undertaken in the United Kingdom.
2025 | 2024 | |||||
(£) | (£) | |||||
Broking commissions and fees earned from corporate finance | 409,413 | 668,816 |
4. Other gains/ (losses)
2025 | 2024 | |||||
(£) | (£) | |||||
Realised (losses) on equity investments | (99,837) | (5,402) | ||||
Unrealised gains/(losses) on equity investments | (31,832) | 250,000 | ||||
Realised gains on equity warrants | 8,847 | - | ||||
Unrealised (losses) on equity warrants | - | (21,594) | ||||
(122,822) | 223,004 |
5. Earnings per share
2025 | 2024 | |||||
Earnings | Earnings | |||||
(£) | (£) | |||||
Based on Profit for the year. | (337,325) | (182,987) | ||||
No. shares | No. shares | |||||
Weighted average number of Ordinary Shares in issue | 105,941,247 | 104,194,580 | ||||
for the purpose of basic earnings per share |
The loss attributable to equity shareholders and weighted average number of ordinary shares for the purposes of calculating diluted earnings per ordinary share are identical to those used for basic earnings per ordinary share. This is because the exercise of share options would have the effect of reducing the loss per ordinary share and is therefore under the terms of IAS33 anti-dilutive.
6. Other matters and Market Abuse Regulation (MAR) Disclosure
The financial information for the year ended 30 April 2025 set out in this announcement does not constitute statutory financial statements, as defined in section 434 of the Companies Act 2006 but is based on the statutory financial statements for the year then ended. The auditors have issued an unqualified opinion on these financial statements; their report included the following statement:
"We have audited the financial statements of Marechale Capital PLC (the 'Company') for the year ended 30 April 2025, which comprise the Income Statement, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity, the Cash Flow Statement, and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and UK adopted International Accounting Standards.
In our opinion the financial statements:
- give a true and fair view of the state of the Company's affairs as at 30 April 2025 and of the loss for the year then ended;
- have been properly prepared in accordance with UK adopted International Accounting Standards; and
- have been prepared in accordance with the requirements of the Companies Act 2006."
7. Related Party Transactions
Company in which the Company holds an investment which have paid fees to the Company
Burgh Island Holdings Ltd ('BI')
The Company owned 10,640 shares, 4% in BI at 30 April 2025 (2024: 4%), BI is a related party through common directorship of Patrick Booth-Clibborn, a director of the Group.
Directors
Patrick Booth-Clibborn
During the year, an interest free travel advance of £5,000 (2024: £5,000) was extended to Mr Booth-Clibborn which is repayable within one year and is included within trade and other receivables on the balance sheet.
Disclosure of control
The company is under the control of its shareholders and not any one party.
Key management personnel
The key management personnel consist of the Directors, whose remuneration is disclosed in the Directors' Report, and the Company Secretary/Financial Officer, Shand FD Ltd ('Shand') whose remuneration in 2025 was £30,014 (2024: £25,964).
The group owed Shand £2,806 at 30 April 2024 (2024: £1,832).
8. Post balance sheet events
There are no past balance sheet events to report
Cautionary statement
Certain statements made in this announcement are forward-looking statements. Such statements are based on current expectations and assumptions and are subject to a number of risks and uncertainties that could cause actual events or results to differ materially from any expected future events or results expressed or implied in these forward-looking statements. Persons receiving this announcement should not place undue reliance on forward-looking statements. Unless otherwise required by applicable law, regulation or accounting standard, the Company does not undertake to update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise.
